BARCLAYS PLC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 122 filers reported holding ANIKA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$499
-21.7%
26,765
+9.0%
0.00%
Q2 2023$637
+7.8%
24,556
+19.4%
0.00%
Q1 2023$591
-19.9%
20,568
-17.6%
0.00%
Q4 2022$738
-99.9%
24,973
-1.3%
0.00%
-100.0%
Q3 2022$602,000
+496.0%
25,313
+457.3%
0.00%
Q2 2022$101,000
-65.5%
4,542
-61.0%
0.00%
Q1 2022$293,000
-78.3%
11,647
-69.1%
0.00%
Q4 2021$1,352,000
+151.3%
37,692
+197.9%
0.00%
Q3 2021$538,000
+38.3%
12,653
+40.8%
0.00%
Q2 2021$389,000
-65.4%
8,986
-67.4%
0.00%
-100.0%
Q1 2021$1,124,000
+4.7%
27,537
+16.0%
0.00%0.0%
Q4 2020$1,074,000
+3.5%
23,730
-19.2%
0.00%0.0%
Q3 2020$1,038,000
+12.3%
29,375
+20.0%
0.00%0.0%
Q2 2020$924,000
+125.9%
24,478
+73.1%
0.00%
Q1 2020$409,000
-71.6%
14,139
-49.2%
0.00%
-100.0%
Q4 2019$1,442,000
-25.3%
27,833
-20.9%
0.00%0.0%
Q3 2019$1,930,000
+49.4%
35,165
+10.6%
0.00%0.0%
Q2 2019$1,292,000
+155.3%
31,799
+90.3%
0.00%
Q1 2019$506,000
+131.1%
16,707
+157.4%
0.00%
Q4 2018$219,000
-74.9%
6,491
-68.7%
0.00%
-100.0%
Q3 2018$872,000
+212.5%
20,707
+138.0%
0.00%
Q2 2018$279,000
-80.7%
8,699
-70.1%
0.00%
-100.0%
Q1 2018$1,447,000
-20.5%
29,093
-13.8%
0.00%0.0%
Q4 2017$1,820,000
+7.2%
33,764
+15.3%
0.00%
-50.0%
Q3 2017$1,698,000
-1.3%
29,282
-16.0%
0.00%0.0%
Q2 2017$1,721,000
+105.1%
34,861
+80.6%
0.00%
+100.0%
Q1 2017$839,000
+152.0%
19,302
+183.1%
0.00%
Q4 2016$333,000
-72.8%
6,819
-73.4%
0.00%
-100.0%
Q3 2016$1,224,000
-15.9%
25,588
-5.7%
0.00%
-50.0%
Q2 2016$1,455,000
-17.8%
27,127
-32.6%
0.00%
-33.3%
Q1 2016$1,770,000
+17.9%
40,218
+1.8%
0.00%
+50.0%
Q4 2015$1,501,000
+157.9%
39,500
+110.4%
0.00%
+100.0%
Q3 2015$582,000
+54.0%
18,777
+63.6%
0.00%
Q2 2015$378,000
+2000.0%
11,479
+2538.9%
0.00%
Q1 2015$18,000
-45.5%
435
-47.1%
0.00%
Q4 2014$33,000
-43.1%
822
-49.0%
0.00%
Q3 2014$58,000
-78.7%
1,611
-72.8%
0.00%
Q2 2014$272,000
+101.5%
5,930
+79.6%
0.00%
Q1 2014$135,000
+10.7%
3,301
+2.9%
0.00%
Q4 2013$122,000
-95.7%
3,208
-97.4%
0.00%
-100.0%
Q3 2013$2,853,000
+7407.9%
124,056
+5343.4%
0.00%
Q2 2013$38,0002,2790.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Trigran Investments, Inc. 954,799$23,975,0002.44%
CAPITAL MANAGEMENT CORP /VA 202,258$5,079,0001.09%
Riverwater Partners LLC 12,370$311,0000.51%
DIKER MANAGEMENT LLC 21,835$548,0000.44%
Ranger Investment Management 136,381$3,425,0000.22%
CHATHAM CAPITAL GROUP, INC. 23,757$597,0000.12%
Teton Advisors, Inc. 22,000$552,0000.10%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,412,259$35,462,0000.09%
Intercontinental Wealth Advisors, LLC 14,257$358,0000.08%
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 385,528$9,681,0000.06%
View complete list of ANIKA THERAPEUTICS INC shareholders